Old Dominion University

ODU Digital Commons
Bioelectrics Publications

Frank Reidy Research Center for Bioelectrics

1-2017

Hyper-Activation of pp60(Src) Limits Nitric Oxide
Signaling by Increasing Asymmetric
Dimethylarginine Levels During Acute Lung Injury
Sanjiv Kumar
Xutong Sun
Satish Kumar Noonepalle
Qing Lu
Evgeny Zemskov
See next page for additional authors

Follow this and additional works at: https://digitalcommons.odu.edu/bioelectrics_pubs
Part of the Biochemistry Commons, Biotechnology Commons, Endocrinology Commons,
Genomics Commons, and the Molecular Biology Commons
Repository Citation
Kumar, Sanjiv; Sun, Xutong; Noonepalle, Satish Kumar; Lu, Qing; Zemskov, Evgeny; Wang, Ting; Aggarwal, Saurabh; Gross,
Christine; Sharma, Shruti; Sesai, Ankit A.; and Catravas, John D., "Hyper-Activation of pp60(Src) Limits Nitric Oxide Signaling by
Increasing Asymmetric Dimethylarginine Levels During Acute Lung Injury" (2017). Bioelectrics Publications. 153.
https://digitalcommons.odu.edu/bioelectrics_pubs/153

Original Publication Citation
Kumar, S., Sun, X. T., Noonepalle, S. K., Lu, Q., Zemskov, E., Wang, T., . . . Black, S. M. (2017). Hyper-activation of pp60src limits
nitric oxide signaling by increasing asymmetric dimethylarginine levels during acute lung injury. Free Radical Biology & Medicine, 102,
217-228. doi:10.1016/j.freeradbiomed.2016.11.008

This Article is brought to you for free and open access by the Frank Reidy Research Center for Bioelectrics at ODU Digital Commons. It has been
accepted for inclusion in Bioelectrics Publications by an authorized administrator of ODU Digital Commons. For more information, please contact
digitalcommons@odu.edu.

Authors

Sanjiv Kumar, Xutong Sun, Satish Kumar Noonepalle, Qing Lu, Evgeny Zemskov, Ting Wang, Saurabh
Aggarwal, Christine Gross, Shruti Sharma, Ankit A. Sesai, and John D. Catravas

This article is available at ODU Digital Commons: https://digitalcommons.odu.edu/bioelectrics_pubs/153

HHS Public Access
Author manuscript
Author Manuscript

Free Radic Biol Med. Author manuscript; available in PMC 2018 January 01.
Published in final edited form as:
Free Radic Biol Med. 2017 January ; 102: 217–228. doi:10.1016/j.freeradbiomed.2016.11.008.

Hyper-activation of pp60Src limits nitric oxide signaling by
increasing asymmetric dimethylarginine levels during acute lung
injury

Author Manuscript

Sanjiv Kumara, Xutong Sunb, Satish Kumar Noonepalleb, Qing Lub, Evgeny Zemskovb, Ting
Wangb, Saurabh Aggarwalc, Christine Grossa, Shruti Sharmad, Ankit A Desaib, Yali Houa,
Sridevi Dasarathya, Ning Qub, Vijay Reddya, Sung Gon Leea, Mary Cherian-Shawa, Jason
X.-J. Yuanb, John D. Catravasd, Ruslan Rafikovb, Joe G.N. Garciab, and Stephen M. Blackb,*
aVascular

Biology Center and the Center for Biotechnology & Genomic Medicine, Augusta
University, Augusta, GA, United States

bDepartment

of Medicine, The University of Arizona, Tucson, AZ, United States

cDepartment

of Anesthesiology, The University of Alabama, Birmingham, AL, United States

dCenter

for Biotechnology & Genomic Medicine, Old Dominion University, Norfolk, VA, United

States

Abstract
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The molecular mechanisms by which the endothelial barrier becomes compromised during
lipopolysaccharide (LPS) mediated acute lung injury (ALI) are still unresolved. We have
previously reported that the disruption of the endothelial barrier is due, at least in part, to the
uncoupling of endothelial nitric oxide synthase (eNOS) and increased peroxynitrite-mediated
nitration of RhoA. The purpose of this study was to elucidate the molecular mechanisms by which
LPS induces eNOS uncoupling during ALI. Exposure of pulmonary endothelial cells (PAEC) to
LPS increased pp60Src activity and this correlated with an increase in nitric oxide (NO)
production, but also an increase in NOS derived superoxide, peroxynitrite formation and 3nitrotyrosine (3-NT) levels. These effects could be simulated by the over-expression of a
constitutively active pp60Src (Y527FSrc) mutant and attenuated by over-expression of dominant
negative pp60Src mutant or reducing pp60Src expression. LPS induces both RhoA nitration and
endothelial barrier disruption and these events were attenuated when pp60Src expression was
reduced. Endothelial NOS uncoupling correlated with an increase in the levels of asymmetric
dimethylarginine (ADMA) in both LPS exposed and Y527FSrc over-expressing PAEC. The
effects in PAEC were also recapitulated when we transiently over-expressed Y527FSrc in the
mouse lung. Finally, we found that the pp60-Src-mediated decrease in DDAH activity was
mediated by the phosphorylation of DDAH II at Y207 and that a Y207F mutant DDAH II was
resistant to pp60Src-mediated inhibition. We conclude that pp60Src can directly inhibit DDAH II
and this is involved in the increased ADMA levels that enhance eNOS uncoupling during the
development of ALI.
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1. Introduction
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In acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) the integrity of
the separation between the alveolus and the pulmonary circulation is compromised either by
endothelial or epithelial injury or more commonly both. This damage leads to increased
vascular permeability, alveolar flooding, and surfactant abnormalities [1]. ALI/ARDS can
occur in response to a number of insults that either directly, or indirectly, produce lung
injury. The most common indirect insult leading to ALI is the release of lipopolysaccharide
(LPS) from the outer bacterial cell wall producing gram negative sepsis [2]. However,
despite significant investigations, the mechanisms underlying the development of ALI/
ARDS are still unresolved and the therapies are predominantly supportive.

Author Manuscript

Recent studies have suggested that endothelial injury in a variety of cardiovascular diseases
is linked to increased levels of the amino acid, asymmetric dimethylarginine (ADMA) [3–7].
ADMA is derived from hydrolysis of methylated proteins [3–7]. The synthesis and
degradation of ADMA can become dysregulated and can result in increased levels of
ADMA [3–7]. ADMA is metabolized via hydrolytic degradation to L-citrulline and
dimethylamine by the enzyme dimethylarginine dimethy-laminohydrolase (DDAH) [7].
There are two isoforms of DDAH: I and II [8,9]. The important isoform in the endothelium
is thought to be DDAH II [6,10]. We have previously shown that during the development of
LPS-induced ALI there is a significant increase in ADMA in the mouse lung, and this is due
to decreased activity, but not expression, of DDAH II [11]. Further, increasing the expression
of DDAH II in the pulmonary endothelium of the lung reduces the development of ALI in
the LPS-exposed mouse [12]. ADMA increases superoxide generation from eNOS and
higher levels of peroxynitrite and protein nitration [11–13]. Peroxynitrite appears to play a
role in the pathogenesis of LPS-lung injury and elevated levels of 3-NT have been identified
in the lung and BAL fluid in ALI [11,14,15]. The importance of eNOS and protein nitration
in the development of ALI has also been shown by the protection afforded eNOS knockout
mice that correlated with a reduction in the nitration-mediated activation of RhoA [16].
RhoA and Rho-associated kinase directly catalyze myosin light chain (MLC)
phosphorylation, or act indirectly via inactivation of MLC, phosphatase to induce cell
contraction and endothelial barrier disruption [17,18].

Author Manuscript

Despite data demonstrating the involvement of the DDAH/ADMA axis in the development
of ALI in the mouse lung, the mechanism by which LPS attenuates DDAH activity is
unresolved. One of the earliest effects of LPS binding to its receptor, TLR4 is the activation
of the subclass A of the Src Family Kinases (SFK), pp60Src. LPS-mediated activation of
pp60Src increases endothelial paracellular permeability [19]. In addition, pp60Src inhibition
attenuates LPS-induced endothe-lial barrier disruption [20]. We have previously shown a
link between ADMA, eNOS uncoupling, and the nitration-mediated activation of RhoA [21]
while prior studies have shown that pp60Src can activate RhoA [22]. However, pp60Src has
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also been shown to stimulate eNOS activity through an Akt1-mediated phosphorylation at
Ser1177 [23]. Ser1177 phosphorylation is thought to stimulate eNOS catalytic activity by
increasing electron flow through the protein [24]. Based on these two opposing facts we
developed a hypothesis that pp60Src signaling induces eNOS uncoupling by both increasing
ADMA levels, through the inhibition of DDAH II, and stimulating eNOS catalytic cycling
through Ser1177 phosphorylation. Our data indicate that pp60Src does inhibit DDAH II
activity through a single phosphorylation at Y207 and that this increases cellular ADMA
levels and eNOS derived superoxide. In addition, the phosphorylation of eNOS at Ser1177 is
stimulated and NO levels also increase, leading to an increase in peroxynitrite generation
and protein nitration. Thus, the role of pp60Src in protein nitration involved in the
development of ALI requires both the activation of eNOS and its uncoupling.

2. Materials and methods
Author Manuscript

2.1. Cell culture
Primary cultures of ovine PAEC were isolated as described previously [25]. Cells were
maintained in DMEM containing phenol red supplemented with 10% fetal calf serum
(Hyclone, Logan, UT), antibiotics, and antimycotics (MediaTech, Herndon, VA) at 37 °C in
a humidified atmosphere with 5% CO2–95% air. Cells were utilized between passages 8 and
12. Between 7 and 8 isolates of PAEC were used to carry out the experimental procedures.
2.2. Animal studies

Author Manuscript

Adult male C57BL/6NHsd mice (7–8 weeks; Harlan, Indianapolis, IN) were used in all
experiments. All animal care and experimental procedures were approved by the Committee
on Animal Use in Research and Education of the Augusta University. Mice were injected
intraperitoneally with Escherichia coli 0111:B4 lipopolysaccharide (LPS; 6.75×104 EU/gm
body wt, Sigma-Aldrich, St. Louis, MO) prepared in 0.9% saline. The control mice received
vehicle (0.9% saline), as previously described [11]. Mice were euthanized 12 h after LPS
injection, and the lungs were flushed with ice-cold EDTA-PBS, excised, snap-frozen in
liquid nitrogen, and stored at −80 °C until used.
2.3. In vivo over-expression of constitutively active pp60Src

Author Manuscript

In vivo, polyethyleneimine derivative transfection reagent (in vivo-jetPEI) was used to
deliver the plasmids, pAd/CMV/V5-DEST-Y527FSrc cDNA or pDST-luciferase, to the
mouse lung endothelium as described previously [12]. Briefly, 40 μg of each plasmid were
incubated with glucose and the jetPEI reagent (Polyplus-transfection Inc, New York, NY), as
per manufacture's instruction for 15–30 min following which the cDNA-jetPEI complexes
were injected into the tail vein.
2.4. Measurement of peroxynitrite and protein nitration levels
The formation of peroxynitrite was determined by the peroxynitrite dependent oxidation of
dihydrorhodamine (DHR) 123 to rhodamine 123 in the presence of PEG-catalase (100U, 30
min), as described previously [12]. Protein nitration was measured via a dot blot procedure,
as previously described [12].
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Total DDAH activity was determined using a radioactive assay to measure the conversion of
L-[3H]-NMMA to [3H]-L-citrulline. Briefly, 20 mg of tissue samples in 125 μl of ice cold
0.1 M sodium phosphate buffer (SPB, pH 6.5) were sonicated and centrifuged at 10,000g for
10 min at 4 °C. Similarly, ovine PAEC grown on 10 cm dishes were harvested in 1 ml of ice
cold SPB and centrifuged at 10,000g for 10 min at 4 °C. The supernatant was removed and
125 μl of ice cold fresh SPB was added to the pellet followed by sonication and
centrifugation at 10,000g for 10 min at 4 °C. The homogenates were analyzed in duplicate
(50 μl), while the remainder was used for protein concentration using the BCA protein assay.
To the supernatant, a reaction mixture was added containing 0.1 M SPB and 0.1 μCi/ml of
L-[3H]-NMMA (specific activity: 1.48–2.96 TBq/mmol) (PerkinElmer, Santa Clara, CA) in
a final volume of 100 μl and incubated for 1 h at 37 °C. The reaction was terminated by
placing the tubes on ice for 5 min and diluting the reaction with 2 ml of ice cold SPB. The
samples were then passed through 1 ml of activated Dowex AG50W-8X cation exchange
resin to remove un-metabolized L-[3H]-NMMA followed by a rinse with 1 ml SPB. The
eluted fractions were mixed with 10 ml of scintillation fluid (ScintiVerse BD Cocktail,
Fisher Scientific, Pittsburgh, PA) and quantified using a liquid scintillation counter. A
reaction mixture containing L-[3H]-NMMA in the absence of enzyme was added to the
Dowex column to determine background counts. DDAH activity is defined as the amount of
L-[3H]-NMMA degraded per hour per mg protein.
2.6. Measurement of ADMA levels

Author Manuscript
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ADMA levels were analyzed by high-performance liquid chromato-graphy (HPLC) as
published previously [11,12]. The crude fraction of cell lysate or lung lysate were isolated
using a solid phase extraction column and subsequently, ADMA was separated using precolumn derivatization with ortho-phthaldialdehyde (OPA) reagent (4.5 mg/mL in borate
buffer, pH 8.5, containing 3.3 μl/mL β-mercaptoethanol) prior to injection. HPLC was
performed using a Shimadzu UFLC system with a Nucleosil phenyl reverse phase column
(4.6×250 mm; Supelco, Bellefonte, PA), equipped with an RF-10AXL fluorescence detector
(Shimadzu USA Manufacturing Corporation). ADMA levels were quantified by
fluorescence detection at 450 nm (emission) and 340 nm (excitation). Mobile phase A was
composed of 95% potassium phosphate (50 mM, pH 6.6), 5% methanol and mobile phase B
was composed of 100% methanol. ADMA was separated using a pre-gradient wash of 25%
mobile phase B (flow rate 0.8 mL/min), followed by a linear increase in mobile phase B
concentration from 20% to 25% over 7 min followed by a constant flow at 25% for 10 min
and another linear increase from 25% to 27% mobile phase B over 5 min followed by
constant flow at 27% mobile phase B for another 7 min. Retention time for ADMA was
approximately 28 min. ADMA concentrations were calculated using standards and an
internal homoarginine standard. The detection limit of the assay was 0.1 μmol/L.
2.7. Expression and purification of endothelial NOS
Wildtype human eNOS and an S1177D eNOS mutant were expressed and purified from
E.coli as previously described [26,27]. NO and superoxide generation from these proteins
was determined as previously described [28].
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2.8. Detection of NOX
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Nitric oxide (NO) generation were measured in the media collected from PAEC overexpressing dominant negative (K295M) or constitu-tively active (Y527F) pp60Src in
response to LPS using an NO-sensitive electrode with a 2-mm diameter tip (ISO-NOP
sensor, WPI) connected to an NO meter (ISO-NO Mark II, WPI) as described previously
[29]. NO levels in the lung lysate were determined by indirect method of measuring the
levels of nitrite as previously described [30]. Briefly, samples were deproteinized by adding
cold ethanol to the sample (1:4 v:v) and then concentrated using a speed-vac. Potassium
iodide/ acetic acid reagent was prepared fresh daily. This reagent was added to a septum
sealed purge vessel and bubbled with nitrogen gas. The gas stream was connected via a trap
containing 1N NaOH, to a Sievers 280i Nitric Oxide Analyzer (GE). Deproteinized samples
were injected with a syringe through a silicone/Teflon septum. Results were analyzed by
measuring the area under curve of the chemiluminescence signal using the Liquid software
(GE).
2.9. Determination of superoxide levels
NOS-derived superoxide levels were estimated by electronic paramagnetic resonance (EPR)
assay using the spin-trap compound 1-hydroxy-3-methoxycarbonyl-2,2,5,5tetramethylpyrrolidine HCl (CMH , Axxora LLC, Farmingdale, NY) in the presence of
ethylisothiourea (ETU, 100 μm, 30 min, Sigma-Aldrich), as previously described [11].
2.10. Generation of a specific DDAH II pY207 antibody

Author Manuscript

The DDAH2 phospho-tyrosine Y207 specific antibody was raised against a synthetic peptide
antigen (MAV LTD HPY(PO4) ASL TLP DDA), where Y(PO4) represent phosphotyrosine.
The peptide was used to immunize rabbits. DDAH2 tyrosine phosphorylation-reactive rabbit
antiserum was first purified by affinity chromatography. Further purification was carried out
using immunodepletion using the non-phosphorylated peptide, MAVLTDHPYASLTLPDDA
resin chromato-graphy, after which the resulting eluate was tested for antibody specificity by
ELISA, and immunoblotting. Relative phosphorylation was determined by stripping and
reprobing blots with an antibody specific for DDAH II.
2.11. Western blot analysis

Author Manuscript

PAEC were treated with LPS for 4 h and solubilized with a lysis buffer containing 1% Triton
X-100, 20 mM Tris. pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% sodium deoxycholate, 0.1%
SDS, and protease inhibitor cocktail (Pierce). Insoluble proteins were precipitated by
centrifugation at 13,000 rpm for 10 min at 4 °C, and the supernatants were then subjected to
SDS-PAGE on 4–20% polyacrylamide gels and transferred to a PVDF membrane (Biorad).
The membranes were blocked with 5% nonfat dry milk or 5% BSA in Tris-buffered saline
containing 0.1% Tween (TBST). The primary antibodies used for immunoblotting were antipp60Src Cell Signaling (1:1000), (Danvers, MA), anti-phospho Y416 pp60Src (1:1000; Cell
Signaling Technology), β-actin (1:5000, Sigma), phospho-Ser1177 eNOS, and anti-eNOS
(1:1000, BD Biosciences) and custom made DDAH II (1:500) and 3NT-Y34-RhoA (1:1000)
[16] antibodies. Membranes were then washed with TBST three times for 10 min, incubated
with the appropriate secondary antibody coupled to horseradish peroxidase, washed again
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with TBST as described above, and the protein bands visualized with ECL reagent (Pierce)
using a Kodak 440CF image station.
2.12. Adenoviral-mediated overexpression of pp60Src mutants
Constitutively active (Y527F) and dominant negative (K295M) pp60Src mutants were
overexpressed using an adenoviral construct as we have previously described [31]. For these
studies, an MOI of 200:1 was used. An adenoviral construct expressing green fluorescent
protein (GFP) was used as a transduction control.
2.13. siRNA-mediated down-regulation of pp60Src

Author Manuscript

PAEC were transfected with the appropriate small interfering RNA (siRNA) using HiPerFect
transfection reagent (Qiagen, Valencia, CA) as described previously [32]. Briefly, the day
before transfection, 1.5×105 cells were seeded in each well of a six-well plate and fresh
DMEM containing serum and antibiotics added. On the day of transfection, the medium was
changed to one without antibiotics. For each well, 6 μl of a 10-μM siRNA stock of pp60Src
(Santa Cruz) or the control (a scrambled siRNA with no known homology to any human
gene) was diluted into 100 μl of DMEM without serum (to give a final siRNA concentration
of 30 nM). To this was added 12 μl of HiPerFect transfection reagent. The solution was
vortexed, incubated for 10 min at room temperature, and added drop-wise to the cells. As the
siRNA's utilized were designed against human mRNA sequences their ability to silence
pp60Src was validated by Western blot analysis 48 h after transfection (Fig. 2A). The cell
culture medium was changed for fresh complete DMEM. LPS was then added at final
concentration 500 EU/ml, the cells were lysed 2– 4 h later, and the lysates were analyzed by
immunoblotting.

Author Manuscript

2.14. Immunoprecipitation analysis

Author Manuscript

For each immunoprecipitation, cell lysates or tissue lysates were subjected to a pre-clearing
step in which the lysates were incubated with a protein G Plus/Protein A agarose suspension
(Calbiochem) for 30 min at 4 °C. The agrose beads were then pelleted and the lysate
removed to a fresh tube and incubated with anti-DDAH II or pp60Src antibodies overnight at
4 °C followed by the addition of the protein G Plus/Protein A agarose suspension for 1 h at
4 °C. The immune complexes were washed three times with the lysis buffer and boiled in
SDS-PAGE sample buffer for 5 min. Agarose beads were pelleted by centrifugation, and the
protein supernatants were loaded and run on 4–20% polyacrylamide gels, followed by
transfer of the proteins to nitrocellulose membranes. The membranes were blocked with 2%
BSA in Tris-buffered saline containing 0.05% Tween 20 (TBST) for 2 h at room
temperature, incubated with anti-phosphotyrosine antibody (Calbiochem) for 2 h at room
temperature, washed three times with TBST (room temperature, 10 min), and then incubated
with a horseradish peroxidase-conjugated secondary antibody (Pierce). The reactive bands
were visualized with the SuperSignal West Femto maximum sensitivity substrate kit (Pierce)
using a Kodak 440CF image station. The same blot was reprobed with anti-DDAH II or
pp60Src antibody to normalize for the levels of catalase immunoprecipitated in each sample.
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2.15. Measurement of endothelial barrier function
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The integrity of PAEC monolayers was characterized using an electrical cell-substrate
impedance sensing (ECIS) instrument (Applied BioPhysics, Troy, NY) as previously
described [21]. Cells were plated in 8-well ECIS arrays (Applied BioPhysics) in DMEM
supplemented with 10%-FBS (50,000 cells per well). Eighteen hours later, cells were
transiently transfected with control or c-Src-specific siRNA's using HiPerFect (Qiagen)
transfection reagent. Sixty hours post-transfection, the cell culture medium was changed for
fresh complete DMEM, and the cells were used in Transendothelial Electrical Resistance
(TER) assay. Initial resistance at the onset of our experiments was 1400–1700 in array wells,
and then all wells were normalized to 1. 4000-Hz AC signal with 1-V amplitude was applied
to the EC monolayers through a 1-M-Ω resistor, creating an approximate constant-current
source (1 μA). After a baseline measurement, the cells were treated with E. coli LPS (50
EU/ml) or vehicle. Changes in TER were recorded in real time. Control curves (LPSuntreated cells) were normalized to 1 in order to eliminate any temporal effects. To take into
account the deviations from control curves, data obtained from LPS-treated cells were
normalized using the original control curves to adjust for the temporal effects that may be
present in controls.
2.16. Statistical analysis
Statistical calculations were performed using the GraphPad Prism V.4.01 software. The
mean ± SE was calculated for all samples, and significance was determined by either the
unpaired or paired t-test or ANOVA. For ANOVA, Newman–Keuls post hoc testing was also
utilized. A value of P < 0.05 was considered significant.

Author Manuscript

3. Results
3.1. Effect of pp60Src on NO signaling in pulmonary arterial endothelial cells

Author Manuscript

The exposure of PAEC to LPS for 4 h significantly increased pp60Src activity as measured
by increase in its phosphorylation at Y416 (Fig. 1A). LPS also increased nitric oxide (NO)
generation in PAEC, which was attenuated by the over-expression of a dominant negative
pp60Src mutant (AdK295MSrc, Fig. 1B). The increase in NO generation correlated with an
LPS-mediated increase in the phosphorylation of eNOS at Ser 1177, which was suppressed
by overexpression of AdK295MSrc (Fig. 1C). The increase in pSer1177 appeared to be Aktdependent as LPS-induced the phosphorylation of Akt at Ser473, indicative of Akt activation
and this was blocked by AdK295MSrc over-expression (Fig. 1D). However, LPS also
increased eNOS-derived superoxide suggesting that the enzyme was becoming uncoupled
(Fig. 1E). Again, AdK295MSrc over-expression attenuated the LPS mediated increased in
NOS-derived superoxide (Fig. 1E). These changes in NO and superoxide led to an increase
in cellular peroxyni-trite levels (Fig. 1F) and total protein nitration (Fig. 1G) which were
reduced by the over-expression of AdK295MSrc (Fig. 1F and G). When pp60Src expression
was attenuated using an siRNA approach (Fig. 2A) this reduced both the LPS-mediated
increase in pS1177eNOS (Fig. 2B) and NOS-derived superoxide levels (Fig. 2C). Silencing
pp60Src expression also prevented the LPS-mediated increase in RhoA nitration (Fig. 2D)
and attenuated the disruption of the endothelial barrier (Fig. 2E).
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3.2. Stimulating pp60Src activity in the mouse lung induces eNOS uncoupling
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To verify in vivo our data in PAEC, we transiently over-expressed a constitutively active
pp60Src mutant (Y527FSrc) mutant in the mouse lung endothelium using the jet-PEI
technique we have recently described [12]. This resulted in a ∼2-fold increase in pp60Src
protein levels (Fig. 3A) and a significant increase in lung pp60Src activity as determined by
increased pY416Src levels (Fig. 3B). The increase in pp60Src activity resulted in a
significant increase in NO levels (Fig. 3C) and p-Ser1177 eNOS (Fig. 3D). Similar to PAEC,
not only did Y527FSrc over-expression in the mouse lung increase NO levels it also
appeared to cause an increased in uncoupling of eNOS as indicated by an increase in NOSderived superoxide (Fig. 3E). As with PAEC, this increase in NO and superoxide resulted in
increased peroxynitrite levels (Fig. 3F) and protein nitration (Fig. 3G).
3.3. An S1177D eNOS mutant protein is uncoupled

Author Manuscript

To further explore the role of eNOS phosphorylation at S1177 in regulating NO and
superoxide generation we utilized purified wildtype and a phospho-mimic S1177D eNOS
mutant. NO and superoxide generation was monitored under conditions that stimulate
maximal velocity of the enzyme [28]. The S1177D mutant generates significantly more NO
than wildtype eNOS (Fig. 4A). However, this mutant also produces significantly more
superoxide as well (Fig. 4B) and overall the coupling index, determined by dividing the
levels of NO by the amount of superoxide generated in each protein, is actually lower in the
S1177D mutant. This suggests that the activation of eNOS by phos-phorylation at S1177
leads to increased catalytic cycling but also enhances eNOS uncoupling.
3.4. LPS increases ADMA levels by attenuating DDAH activity

Author Manuscript
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We have previously shown that LPS increases the endogenous eNOS uncoupler, ADMA in
the mouse lung by attenuating DDAH activity [13]. As in the mouse lung [11], LPS did not
change DDAH II protein levels in PAEC either in the absence or presence of AdK295MSrc
(Fig. 5A). However, LPS did significantly reduce DDAH activity (Fig. 5B) and increase
cellular ADMA levels (Fig. 5C). These changes were attenuated by the over-expression of
AdK295MSrc implicating pp60Src in the mechanism by which LPS inhibits DDAH activity.
To further investigate the mechanism by which pp60Src inhibits DDAH activity we treated
PAEC with LPS and used immuno-precipitation analyses to determine if there was a specific
interaction of pp60Src with DDAH II, the predominant endothelial isoform [6,10]. Our data
indicate that in PAEC, LPS stimulates the interaction of pp60Src with DDAH II (Fig. 6A)
and this correlates with an increase in pY-DDAH II (Fig. 6B). Similarly, in the LPS exposed
mouse lung, there is a significant increase in the interaction of pp60Src with DDAH II (Fig.
6C) and pYDDAH II levels (Fig. 6D).
3.5. Over-expression of a constitutively active pp60Src mutant mimics the effects of LPS on
DDAH activity
To further demonstrate the functional significance of pp60Src in attenuating DDAH activity,
we overexpressed a constitutively active pp60Src mutant in PAEC using an adenovirus
containing Y527FSrc (AdY527FSrc, Fig. 7A). This over-expression increased pY416
pp60Src levels, indicating increased pp60Src activity (Fig. 7B) but again did not change
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DDAH II protein levels (Fig. 7C). As with LPS, AdY527FSrc over-expression increased the
interaction of pp60Src with DDAH II (Fig. 7D), pY-DDAH II levels (Fig. 7E), decreased
DDAH activity (Fig. 7F) and increased ADMA levels (Fig. 7G). Thus, the stimulation of
pp60Src signaling is sufficient to mimic the effects of LPS on the DDAH/ ADMA axis.
Similarly, overexpression of Y527FSrc in the mouse lung did not significantly alter DDAH
II protein levels (Fig. 8A). However, the interaction of DDAH II with pp60Src was
significantly increased (Fig. 8B) as was pY-DDAH II (Fig. 8C). These changes correlated
with a decrease in DDAH activity (Fig. 8D) and an increase in ADMA levels (Fig. 8E).
3.6. pp60Src mediates its inhibitory effect on DDAH II through Y207
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An analysis of the human DDAH II protein revealed the presence of a single tyrosine residue
located at amino acid position 207. To determine if phosphorylation of this residue was
responsible for mediating the pp60Src-dependent decrease in DDAH activity we generated a
phospho-antibody that recognizes pY207 in DDAH II. Using this antibody we were able to
demonstrate an increase in the phosphorylation of Y207 in DDAH II in PAEC overexpressing Y527FSrc (Fig. 9A). Then, using side-directed mutagenesis we replaced the
tyrosine at 207 with phenylalanine to generate a Y207F DDAH II mutant. We then coexpressed wild-type and Y207F-DDAH II with Y527FSrc in HEK293 cells (Fig. 9B and C).
The over-expression of Y527FSrc decreased DDAH activity (Fig. 9D) and increased ADMA
levels (Fig. 9E) in cells expressing wild-type DDAH II. However, Y527FSrc did not alter
DDAH activity (Fig. 9D) and ADMA levels (Fig. 9E) in cells over-expressing the Y207F
DDAH II mutant. These results confirm that pp60Src attenuates DDAH II activity through a
specific phosphorylation at Y207.

4. Discussion
Author Manuscript
Author Manuscript

The most significant finding in this study is the identification of pp60Src as a kinase capable
of binding to, and directly inhibiting the activity of, DDAH II and resulting in an increase in
cellular ADMA. As ADMA is an endogenous NOS inhibitor, this attenuates NO generation
for eNOS by enhancing its uncoupling [13]. This occurs despite a pp60Src–mediated
increase in eNOS phosphorylation at Ser1177. Phosphorylation of eNOS at Ser1177 is
thought to stimulate enzymatic activity by making the enzyme calcium/calmodulin
independent [33], or more likely, it makes the enzyme more responsive to lower levels of
calcium. Although the phosphorylation of eNOS at Thr495 is more often associated with
eNOS uncoupling [34], Ser1177 phosphorylation has also been associated with the
uncoupling of eNOS [24]. In addition, a mutant eNOS protein that has an aspartic acid
introduced at Ser1177, to mimic phosphorylation, in combination with an alanine at Thr495,
to prevent its phosphorylation, is uncoupled [35]. Our S1177D eNOS mutant data which
appears to have increased catalytic activity, at the cost of increased superoxide generation, is
thus in agreement with prior studies. However, we speculate that the LPS-mediated increases
in ADMA likely synergize with the phosphorylation of eNOS at Ser1177 to further stimulate
eNOS uncoupling and together this results in increased peroxynitrite production and protein
nitration we observe in both cultured PAEC and the mouse lung. Further, as our prior studies
suggest that eNOS rather than iNOS may play a more important role in the development of
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ALI [11,16,21], attenuating eNOS uncoupling could be a potential therapeutic target for
treating a disease that, besides low tidal mechanical ventilation, has no viable therapy.
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In the pulmonary vasculature, and other vascular beds, eNOS utilizes L-arginine to produce
L-citrulline and NO [36]. Although a simple reaction, a complex regulatory network is
required to maintain sufficient NO generation and a healthy endothelium. Besides, its
substrate, L-arginine, the generation of NO requires the binding of Ca2+/calmodulin, flavin
adenine dinucleotide, flavin mononucleotide, NADPH, and tetrahydrobiopterin (BH4) [37].
If the levels of L-arginine or BH4 decrease, electrons donated by NADPH are utilized to
convert molecular oxygen to superoxide, a process known as uncoupling [38]. Another
factor that can induce eNOS uncoupling is ADMA. ADMA competes with L-arginine for
the substrate binding site in eNOS, and the ratio between L-arginine and ADMA is a key
component in the regulation of endothelial NOS activity. Elevated ADMA levels have been
shown to antagonize the endothelium-dependent vasodilation in humans [3–7]. Increased
levels of ADMA have been identified in a number of pulmonary diseases including
pulmonary hypertension [39], congenital heart disease (CHD) [40], and ALI [11,12].
ADMA appears to increase secondary to a reduction in the activity of the ADMA
metabolizing enzyme, DDAH II. In humans with PH [41] and piglets with persistent
pulmonary hypertension of the newborn [42] this correlates with a reduction in DDAH II
expression. While in lambs with CHD [40] and mice exposed to LPS [11,12] DDAH II
protein levels are unchanged but activity is decreased. Similarly, in vitro studies have shown
that oxidized LDL [43], TNF-α [43], and hypergly-cemia [44] decrease DDAH activity, but
not its expression. The molecular mechanism by which the post-translational inhibition of
DDAH II occurs has been unresolved. Thus, our data add significantly to our understanding
of how this process occurs by identifying a pp60Src-mediated phosphorylation of DDAH II
on Y207 as the inhibitory phosphorylation. Further, our data fit well with the prior studies
that identified oxidative stress [43,44] as being important in DDAH II inhibition as pp60Src
can be activated by reactive oxygen species [45–47]. However, further studies will be
required to determine if pp60Src activation is a common mechanism responsible for the
inhibition of DDAH II activity in other pulmonary diseases such as CHD [40].

Author Manuscript

It is well established that pp60Src plays a major role in the endothelial barrier disruption
associated with ALI [48–50] and pp60Src inhibition attenuates the severity of injury [20].
However, pp60Src has also been shown to indirectly enhance eNOS activity and NO
generation through the sequential signaling of PI3 kinase and Akt1 [23]. NO signaling
appears to be involved in maintaining the endothe-lial barrier under physiologic conditions
[51–54] and can protect against its disruption by oxidative stress [54,55]. These findings are
apparently contradictory. However, we show that pp60Src activation leads to both NO and
superoxide generation and the formation of peroxynitrite. A number of studies have shown
that peroxynitrite, generated by the interaction of NO with superoxide, plays an important
role in the disruption of the endothelial barrier during the development of ALI/ARDS
[11,14,15]. Peroxynitrite can lead to protein tyrosine nitration forming 3-nitrotyrosine (3NT). 3-NT is widely used as a marker of peroxynitrite formation and elevated levels have
been found in animal models of ALI [11,56–59] and in patients with ALI [60]. We have
shown that scavenging peroxynitrite can attenuate the development of ALI [11]. However,
the key protein targets for nitration in ALI are only poorly understood. Indeed, to our
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knowledge, the only verified nitration target in ALI is the Rho (Ras homologous) GTPbinding protein, RhoA [21]. The canonical pathway by which RhoA is stimulated is via the
activation of G-protein-coupled receptors and/or tyrosine kinases that results in the
activation of guanine nucleotide exchange factors (GEFs) inducing the exchange of GDP for
GTP and translocation of GTP-RhoA to the plasma membrane. Upon transloca-tion to the
plasma membrane RhoA is able to activate one or more of its effector proteins, particularly
Rho-associated kinases (ROCKs). Rho A and Rho-associated kinase can directly catalyze
myosin light chain (MLC) phosphorylation, or act indirectly via inactivation of MLC
phosphatase [17,18] inducing cell contraction and endothelial barrier disruption. However,
when nitrated at Y34, the need for GEFs are minimized as the nitration of Y34 enhances
GDP release mimicking the effect of GEFs [21]. Our data confirm that pp60Src is required
for RhoA nitration in LPS-exposed PAEC, likely due to increased eNOS uncoupling and that
decreasing RhoA nitration correlates with reduced endothelial barrier disruption in response
to LPS. Another potential target for nitration is nuclear factor (NF)-κB. The NF-κB family
of transcription factors regulate the generation of cytokines/chemokines in response to
various injurous states including oxidative and nitrative stress. The activation of NF-κB is
well established in ALI [61,62]. Under basal conditions, NF-κB is sequestered in the
cytoplasm in a complex with IκBα. In a previous study, we have demonstrated that the
nitration of IκBα at Y181 triggers its dissociation from NF-κB leading to its nuclear
accumulation [63]. In addition, our prior studies have shown that reducing protein nitration,
by over-expressing either DDAH II in the pulmonary endothelium of the mouse [12] or
using eNOS-/mice [16], reduces the inflammatory cytokines normally induced by LPS via
NF-κB again implicating eNOS rather than iNOS in the progression of ALI. Thus, although
correlative, this is highly suggestive that NF-κB nitration may be involved in its noncanonical activation during ALI. However, further studies will be required to test this
hypothesis.
In conclusion our data indicate that during ALI, the activation of pp60Src through the
uncoupling of eNOS drives the generation of peroxynitrite and enhances protein nitration,
with at least one of the nitration targets being the barrier disruptive small GTPase, RhoA.
This is mediated by increasing ADMA levels via the inhibition of DDAH II and through an
increase in Ser1177 eNOS phosphorylation. These data again suggest that treatments that
target the increased generation of ADMA during ALI may have therapeutic value.
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The over-expression of a dominant negative pp60Src stimulates eNOS uncoupling in
pulmonary arterial endothelial cells. PAEC were exposed to LPS (1000 EU/ml; 4 h). LPS
increased pp60Src activity as measured by increase in its phosphorylation at Y416 (A).
PAEC were also transduced with an adenovirus containing either a dominant negative
pp60Src (AdK295MSrc) or GFP. After 48 h the cells were challenged with LPS (1000
EU/ml; 4 h). LPS increased NO generation (B) and this correlated with an increase in pSer1177 eNOS (C) mediated via Akt1 as indicated by increased p-Ser473 Akt1 levels (D).
All these effects were attenuated by AdK295MSrc over-expression (insert, panel B).
AdK295MSrc also attenuated the LPS mediated increase in NOS-derived superoxide as
estimated using EPR (E). LPS also increased peroxynitrite generation (F) and 3nitrotyrosine (3-NT) levels (G). These effects were again attenuated by overexpression of
AdK295MSrc. Values are mean ± SEM, n=3–6, *P < 0.05 vs. untreated; †P < 0.05 vs. LPS.
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Decreasing pp60Src expression attenuated RhoA nitration and preserves the endothelial
barrier. PAEC were transiently transfected with a siRNA for pp60Src or a control siRNA for
48 h to decrease pp60Src expression (A). Cells were then exposed to LPS (500 EU/ml) for 2–
4 h. Whole-cell lysates (20 μg) were prepared, and pS1177eNOS levels determined by
immunoblotting with anti-pS1177eNOS. Loading was normalized by re-probing the
membranes with an antibody specific to total eNOS. The depletion of pp60Src significantly
reduces the LPS-mediated p-S1177 eNOS levels (B). Decreasing pp60Src expression also
attenuated the LPS mediated increase in NOS-derived superoxide, as estimated using EPR
(C). LPS also increased the nitration of RhoA as determined by Western blot analysis using
an antibody that specifically recognizes the nitration of Y34 in RhoA (Nit-RhoA, D). Again
the depletion of pp60Src significantly reduces the LPS-mediated nitration of RhoA (D).
Loading was normalized by re-probing the membranes with an antibody specific to β-actin.
Depleting pp60Src also attenuates the barrier disruption associated with LPS (50 EU/ml, E).
Values are mean ± SEM, n=4–6, *P < 0.05 vs. scr siRNA; †P < 0.05 vs. LPS+Scr siRNA.
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Enhancing pp60Src activity in the mouse lung induces eNOS uncoupling. Mice were injected
with either DST-luciferase (DST) or pAD/CMV/V5-DEST-CApp60Src (Y527FSrc) plasmids
via a tail vein injection. After 72 h, the animals were sacrificed and peripheral lung lysates
prepared. Mice injected with Y527FSrc had a significant increase in pp60Src protein levels
(A) and increase in pp60Src activity, as determined by increase in phospho-Y416 Src (B).
The increase in pp60Src activity resulted in an increase in NO generation (C) and p-Ser1177
eNOS levels (D). Over-expression of Y527FSrc in the mouse lung also significantly
increased the levels NOS-derived superoxide (E), peroxynitrite (F), and 3-NT protein (G).
Values are mean ± SEM, n=4–16, *P<0.05 vs. DST.
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Fig. 4.

An S1177D eNOS mutant is catalytically more active but uncoupled. NO (A) and
superoxide (B) generation are both significantly higher in the p-S1177 eNOS mimic protein,
S1177D eNOS compared to the wildtype enzyme. The eNOS coupling index, determined as
the ratio between NO and superoxide generation, was significantly decreased in the S1177D
eNOS mutant suggesting the protein is more uncoupled (C). Values are mean ± SEM, n=3,
*P < 0.05 vs. wildtype eNOS.
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Fig. 5.

LPS decreases DDAH activity and increases ADMA levels in pulmonary arterial endothelial
cells. PAEC were transduced with AdK295MSrc or AdGFP for 48 h then challenged with
LPS (1000 EU/ml; 4 h). Although DDAH II protein levels were unchanged (A), LPS
attenuated DDAH (B) activity and increased ADMA levels (B). AdK295MSrc prevented
both the decrease in DDAH activity (B) and the increase in ADMA (C). Values are mean ±
SEM, n=4–11, * P < 0.05 vs. untreated; †P < 0.05 vs. LPS.
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The decrease in DDAH activity corresponds to an increase in pp60Src-mediated
phosphorylation of DDAH II. PAEC were exposed to LPS (1000 EU/ml; 4 h) then lysates
were subjected to immunoprecipitation and immunoblotting using pp60Src with DDAH II
specific antibodies. LPS stimulates the interaction of interaction of pp60Src and DDAH II
(A) and this correlates with an increase in the tyrosine phosphorylation of DDAH II (B).
Mice were also injected with LPS (6.75×104 EU/gm body wt.) intraperitoneally. After 12 h
lung lysates were prepared and subjected to immunoprecipitation and immuno-blotting. LPS
treatment increases both the interaction of pp60Src and DDAH II in the moue lung (D) and
the tyrosine phosphorylation of DDAH II (E). Values are mean ± SEM, n=4–12, * P < 0.05
vs. untreated. LPS.
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The over-expression of a constitutively active pp60Src mutant mimics the effects of LPS on
DDAH activity in pulmonary arterial endothelial cells. PAEC were transduced with
AdY527FSrc or AdGFP for 48 h. Immunoblot analysis identified a significant increase in
pp60Src protein levels (A) and an increase in pp60Src activity, as determine by increase in
phospho-Y416 pp60Src levels (B) in PAEC transduced with AdY527FSrc. AdY527FSrc did
not alter DDAH II protein levels (C). However, AdY527FSrc transduction significantly
increased the both the interaction of pp60Src with DDAH II (D) and the tyrosine
phosphorylation of DDAH II (E). DDAH activity was significantly decreased (F) while
ADMA levels were significantly increased (G). Values are mean ± SEM, n=4–6, * P < 0.05
vs. AdGFP.
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Fig. 8.

The over-expression of a constitutively active pp60Src mutant in decreases DDAH activity
and increases ADMA levels in the mouse lung. Mice were injected with either DSTluciferase (DST) or pAD/CMV/V5-DEST- Y527FSrc (Y527FSrc) plasmids via the tail vein.
After 72 h, the animals were sacrificed and peripheral lung lysates prepared. Y527FSrc overexpression dis not alter DDAH II protein levels (A). However, the interaction of pp60Src
with DDAH II was significantly increased (B) as was the tyrosine phosphorylation of DDAH
II (C). DDAH activity (D) was significantly reduced and ADMA levels were significantly
increased (E). Values are mean ± SEM, n=5–6, *P < 0.05 vs. DST-Luc.
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pp60Src inhibits DDAH II activity through Y207. HEK293 cells were transduced
AdY527FSrc or AdGFP along with wild-type DDAH II for 48 h. Over-expression of
Ad527FSrc increased pY207 DDAH II levels as measured by Western blot analysis using a
phospho-antibody that recognizes pY207 in DDAH II (A). HEK293 were transduced with
(AdY527FSrc) or AdGFP and transfected with either wildtype (WT) DDAH II or a DDAH
II mutant in which Y207 was replaced by phenlyalanine (Y207FDDAH II). Immunoblot
analysis identified a similar increase in DDAH II levels in WT DDAH II or Y207F DDAH II
transfected cells (B). HEK293 cells transduced with AdY527FSrc exhibited a significant
increase in pp60Src expression (C). The over-expression of AdY527FSrc decreased DDAH
II activity (D) and increased ADMA levels (E) in cells expressing WT DDAH II. However,
AdY527FSrc did decrease DDAH activity (D) or increase ADMA levels (E) levels in cells

Free Radic Biol Med. Author manuscript; available in PMC 2018 January 01.

Kumar et al.

Page 25

Author Manuscript

expressing the Y207F DDAH II mutant. Values are mean± SEM, n=4–6, *P< 0.05 vs. WT
DDAH II alone.
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